Skip to main content
Top
Published in: BMC Infectious Diseases 1/2014

Open Access 01-12-2014 | Research article

The geographic distribution patterns of HIV-, HCV- and co-infections among drug users in a national methadone maintenance treatment program in Southwest China

Authors: Yi-Biao Zhou, Song Liang, Qi-Xing Wang, Yu-Han Gong, Shi-Jiao Nie, Lei Nan, Ai-Hui Yang, Qiang Liao, Xiu-Xia Song, Qing-Wu Jiang

Published in: BMC Infectious Diseases | Issue 1/2014

Login to get access

Abstract

Background

HIV-, HCV- and HIV/HCV co-infections among drug users have become a rapidly emerging global public health problem. In order to constrain the dual epidemics of HIV/AIDS and drug use, China has adopted a methadone maintenance treatment program (MMTP) since 2004. Studies of the geographic heterogeneity of HIV and HCV infections at a local scale are sparse, which has critical implications for future MMTP implementation and health policies covering both HIV and HCV prevention among drug users in China. This study aimed to characterize geographic patterns of HIV and HCV prevalence at the township level among drug users in a Yi Autonomous Prefecture, Southwest of China.

Methods

Data on demographic and clinical characteristics of all clients in the 11 MMTP clinics of the Yi Autonomous Prefecture from March 2004 to December 2012 were collected. A GIS-based geographic analysis involving geographic autocorrelation analysis and geographic scan statistics were employed to identify the geographic distribution pattern of HIV-, HCV- and co-infections among drug users.

Results

A total of 6690 MMTP clients was analyzed. The prevalence of HIV-, HCV- and co-infections were 25.2%, 30.8%, and 10.9% respectively. There were significant global and local geographic autocorrelations for HIV-, HCV-, and co-infection. The Moran’s I was 0.3015, 0.3449, and 0.3155, respectively (P < 0.0001). Both the geographic autocorrelation analysis and the geographic scan statistical analysis showed that HIV-, HCV-, and co-infections in the prefecture exhibited significant geographic clustering at the township level. The geographic distribution pattern of each infection group was different.

Conclusion

HIV-, HCV-, and co-infections among drug users in the Yi Autonomous Prefecture all exhibited substantial geographic heterogeneity at the township level. The geographic distribution patterns of the three groups were different. These findings imply that it may be necessary to inform or invent site-specific intervention strategies to better devote currently limited resource to combat these two viruses.
Appendix
Available only for authorised users
Literature
1.
go back to reference Kim AY, Onofrey S, Church DR: An epidemiologic update on hepatitis C infection in persons living with or at risk of HIV infection. J Infect Dis. 2013, 207 (Suppl 1): S1-6. 10.1093/infdis/jis927.CrossRefPubMedPubMedCentral Kim AY, Onofrey S, Church DR: An epidemiologic update on hepatitis C infection in persons living with or at risk of HIV infection. J Infect Dis. 2013, 207 (Suppl 1): S1-6. 10.1093/infdis/jis927.CrossRefPubMedPubMedCentral
2.
go back to reference De Cock KM, Jaffe HW, Curran JW: The evolving epidemiology of HIV/AIDS. AIDS. 2012, 26 (10): 1205-1213. 10.1097/QAD.0b013e328354622a.CrossRefPubMed De Cock KM, Jaffe HW, Curran JW: The evolving epidemiology of HIV/AIDS. AIDS. 2012, 26 (10): 1205-1213. 10.1097/QAD.0b013e328354622a.CrossRefPubMed
3.
go back to reference Strader DB: Coinfection with HIV and hepatitis C virus in injection drug users and minority populations. Clin Infect Dis. 2005, 41 (Suppl 1): S7-13.CrossRefPubMed Strader DB: Coinfection with HIV and hepatitis C virus in injection drug users and minority populations. Clin Infect Dis. 2005, 41 (Suppl 1): S7-13.CrossRefPubMed
4.
go back to reference China Ministry of Health, UNAIDS, WHO: Estimation of the AIDS epidemic in China in 2011. Chin J AIDS STD. 2012, 18 (1): 1-5. (in Chinese) China Ministry of Health, UNAIDS, WHO: Estimation of the AIDS epidemic in China in 2011. Chin J AIDS STD. 2012, 18 (1): 1-5. (in Chinese)
6.
go back to reference Sherman KE, Rouster SD, Chung RT, Rajicic N: Hepatitis C virus prevalence among patients infected with human immunodeficiency virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group. Clin Infect Dis. 2002, 34: 831-837. 10.1086/339042.CrossRefPubMed Sherman KE, Rouster SD, Chung RT, Rajicic N: Hepatitis C virus prevalence among patients infected with human immunodeficiency virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group. Clin Infect Dis. 2002, 34: 831-837. 10.1086/339042.CrossRefPubMed
7.
go back to reference Tan Y, Wei QH, Chen LJ, Chan PC, Lai WS, He ML, Kung HF, Lee SS: Molecular epidemiology of HCV monoinfection and HIV/HCV coinfection in injection drug users in Liuzhou. Southern China. PLoS One. 2008, 3 (10): e3608-10.1371/journal.pone.0003608.CrossRefPubMed Tan Y, Wei QH, Chen LJ, Chan PC, Lai WS, He ML, Kung HF, Lee SS: Molecular epidemiology of HCV monoinfection and HIV/HCV coinfection in injection drug users in Liuzhou. Southern China. PLoS One. 2008, 3 (10): e3608-10.1371/journal.pone.0003608.CrossRefPubMed
9.
go back to reference Aceijas C, Rhodes T: Global estimates of prevalence of HCV infection among injecting drug users. Int J Drug Policy. 2007, 18: 352-358. 10.1016/j.drugpo.2007.04.004.CrossRefPubMed Aceijas C, Rhodes T: Global estimates of prevalence of HCV infection among injecting drug users. Int J Drug Policy. 2007, 18: 352-358. 10.1016/j.drugpo.2007.04.004.CrossRefPubMed
10.
go back to reference Zhou YH, Liu FL, Yao ZH, Duo L, Li H, Sun Y, Zheng YT: Comparison of HIV-, HBV-, HCV- and co-infection prevalence between Chinese and Burmese intravenous drug users of the China-Myanmar border region. PLoS One. 2011, 6 (1): e16349-10.1371/journal.pone.0016349.CrossRefPubMedPubMedCentral Zhou YH, Liu FL, Yao ZH, Duo L, Li H, Sun Y, Zheng YT: Comparison of HIV-, HBV-, HCV- and co-infection prevalence between Chinese and Burmese intravenous drug users of the China-Myanmar border region. PLoS One. 2011, 6 (1): e16349-10.1371/journal.pone.0016349.CrossRefPubMedPubMedCentral
11.
go back to reference Yin W, Hao Y, Sun X, Gong X, Li F, Li J, Rou K, Sullivan SG, Wang C, Cao X: Scaling up the national methadone maintenance treatment program in China: achievements and challenges. Int J Epidemiol. 2010, 39 (2): ii29-37.PubMedPubMedCentral Yin W, Hao Y, Sun X, Gong X, Li F, Li J, Rou K, Sullivan SG, Wang C, Cao X: Scaling up the national methadone maintenance treatment program in China: achievements and challenges. Int J Epidemiol. 2010, 39 (2): ii29-37.PubMedPubMedCentral
12.
go back to reference Zhuang X, Liang Y, Chow EP, Wang Y, Wilson DP, Zhang L: HIV and HCV prevalence among entrants to methadone maintenance treatment clinics in China: a systematic review and meta-analysis. BMC Infect Dis. 2012, 12: 130-10.1186/1471-2334-12-130.CrossRefPubMedPubMedCentral Zhuang X, Liang Y, Chow EP, Wang Y, Wilson DP, Zhang L: HIV and HCV prevalence among entrants to methadone maintenance treatment clinics in China: a systematic review and meta-analysis. BMC Infect Dis. 2012, 12: 130-10.1186/1471-2334-12-130.CrossRefPubMedPubMedCentral
13.
go back to reference Zhou YB, Liang S, Chen GX, Rea C, Han SM, He ZG, Li YP, Wei JG, Zhao GM, Jiang QW: Spatial-temporal variations of Schistosoma japonicum distribution after an integrated national control strategy: a cohort in a marshland area of China. BMC Public Health. 2013, 13: 297-10.1186/1471-2458-13-297.CrossRefPubMedPubMedCentral Zhou YB, Liang S, Chen GX, Rea C, Han SM, He ZG, Li YP, Wei JG, Zhao GM, Jiang QW: Spatial-temporal variations of Schistosoma japonicum distribution after an integrated national control strategy: a cohort in a marshland area of China. BMC Public Health. 2013, 13: 297-10.1186/1471-2458-13-297.CrossRefPubMedPubMedCentral
14.
go back to reference Pang L, Hao Y, Mi G, Mi G, Wang C, Luo W, Rou K, Li J, Wu Z: Effectiveness of first eight methadone maintenance treatment clinics in China. AIDS. 2007, 21 (8): S103-107.CrossRefPubMed Pang L, Hao Y, Mi G, Mi G, Wang C, Luo W, Rou K, Li J, Wu Z: Effectiveness of first eight methadone maintenance treatment clinics in China. AIDS. 2007, 21 (8): S103-107.CrossRefPubMed
15.
go back to reference Du WJ, Xiang YT, Wang ZM, Chi Y, Zheng Y, Luo XN, Cai ZJ, Ungvari GS, Gerevich J: Socio-demographic and clinical characteristics of 3129 heroin users in the first methadone maintenance treatment clinic in China. Drug Alcohol Depend. 2008, 94 (1–3): 158-164.CrossRefPubMed Du WJ, Xiang YT, Wang ZM, Chi Y, Zheng Y, Luo XN, Cai ZJ, Ungvari GS, Gerevich J: Socio-demographic and clinical characteristics of 3129 heroin users in the first methadone maintenance treatment clinic in China. Drug Alcohol Depend. 2008, 94 (1–3): 158-164.CrossRefPubMed
16.
go back to reference Assunção RM, Reis EA: A new proposal to adjust Moran’s I for population density. Stat Med. 1999, 18: 2147-2161. 10.1002/(SICI)1097-0258(19990830)18:16<2147::AID-SIM179>3.0.CO;2-I.CrossRefPubMed Assunção RM, Reis EA: A new proposal to adjust Moran’s I for population density. Stat Med. 1999, 18: 2147-2161. 10.1002/(SICI)1097-0258(19990830)18:16<2147::AID-SIM179>3.0.CO;2-I.CrossRefPubMed
17.
go back to reference Kulldorff M: Spatial scan statistic. Commun Statist - Theory Meth. 1997, 26: 1481-1496. 10.1080/03610929708831995.CrossRef Kulldorff M: Spatial scan statistic. Commun Statist - Theory Meth. 1997, 26: 1481-1496. 10.1080/03610929708831995.CrossRef
18.
go back to reference Kulldorff M, Nagarwalla N: Spatial disease clusters: detection and inference. Stat Med. 1995, 14: 799-810. 10.1002/sim.4780140809.CrossRefPubMed Kulldorff M, Nagarwalla N: Spatial disease clusters: detection and inference. Stat Med. 1995, 14: 799-810. 10.1002/sim.4780140809.CrossRefPubMed
19.
go back to reference Dwass M: Modified randomization tests for nonparametric hypotheses. Ann Math Stat. 1957, 28: 181-187. 10.1214/aoms/1177707045.CrossRef Dwass M: Modified randomization tests for nonparametric hypotheses. Ann Math Stat. 1957, 28: 181-187. 10.1214/aoms/1177707045.CrossRef
20.
go back to reference Dai S, Shen Z, Zha Z, Leng R, Qin W, Wang C, Chen L, Tian M, Huang Z, Chen G, Cen H, Xue L, Wang J, Lu Y, Cao B, Ye D: Seroprevalence of HIV, syphilis, and hepatitis C virus in the general population of the Liangshan Prefecture, Sichuan Province. China. J Med Virol. 2012, 84 (1): 1-5. 10.1002/jmv.22214.CrossRefPubMed Dai S, Shen Z, Zha Z, Leng R, Qin W, Wang C, Chen L, Tian M, Huang Z, Chen G, Cen H, Xue L, Wang J, Lu Y, Cao B, Ye D: Seroprevalence of HIV, syphilis, and hepatitis C virus in the general population of the Liangshan Prefecture, Sichuan Province. China. J Med Virol. 2012, 84 (1): 1-5. 10.1002/jmv.22214.CrossRefPubMed
21.
go back to reference Zhang SZ, Yin BB, Gong YH, Leng R, Qin W, Wang C, Chen L, Tian M, Huang Z, Chen G: The virology effect of AIDS antivirus therapy and its associated factors in the Yi Autonomous Prefecture. Chin J Pre Med. 2012, 46 (11): 1036-1037. (in Chinese) Zhang SZ, Yin BB, Gong YH, Leng R, Qin W, Wang C, Chen L, Tian M, Huang Z, Chen G: The virology effect of AIDS antivirus therapy and its associated factors in the Yi Autonomous Prefecture. Chin J Pre Med. 2012, 46 (11): 1036-1037. (in Chinese)
22.
go back to reference Vickerman P, Hickman M, May M, Kretzschmar M, Wiessing L: Can hepatitis C virus prevalence be used as a measure of injection-related human immunodeficiency virus risk in populations of injecting drug users? An ecological analysis. Addiction. 2010, 105 (2): 311-318. 10.1111/j.1360-0443.2009.02759.x.CrossRefPubMed Vickerman P, Hickman M, May M, Kretzschmar M, Wiessing L: Can hepatitis C virus prevalence be used as a measure of injection-related human immunodeficiency virus risk in populations of injecting drug users? An ecological analysis. Addiction. 2010, 105 (2): 311-318. 10.1111/j.1360-0443.2009.02759.x.CrossRefPubMed
23.
go back to reference Vickerman P, Martin NK, Hickman M: Understanding the trends in HIV and hepatitis C prevalence amongst injecting drug users in different settings–implications for intervention impact. Drug Alcohol Depend. 2012, 123 (1–3): 122-131.CrossRefPubMed Vickerman P, Martin NK, Hickman M: Understanding the trends in HIV and hepatitis C prevalence amongst injecting drug users in different settings–implications for intervention impact. Drug Alcohol Depend. 2012, 123 (1–3): 122-131.CrossRefPubMed
24.
go back to reference de Vos AS, van der Helm JJ, Prins M, Kretzschmar ME: Determinants of persistent spread of HIV in HCV-infected populations of injecting drug users. Epidemics. 2012, 4 (2): 57-67. 10.1016/j.epidem.2012.01.001.CrossRefPubMed de Vos AS, van der Helm JJ, Prins M, Kretzschmar ME: Determinants of persistent spread of HIV in HCV-infected populations of injecting drug users. Epidemics. 2012, 4 (2): 57-67. 10.1016/j.epidem.2012.01.001.CrossRefPubMed
25.
go back to reference Yang Y, Luan RS, Liu P, Wu CL, Zhou Y, Chen W: Casualsex and concurrent sexual partnerships among young people from an Yi community with a high prevalence of HIV in China. Asian J Androl. 2012, 14 (5): 758-765. 10.1038/aja.2012.25.CrossRefPubMedPubMedCentral Yang Y, Luan RS, Liu P, Wu CL, Zhou Y, Chen W: Casualsex and concurrent sexual partnerships among young people from an Yi community with a high prevalence of HIV in China. Asian J Androl. 2012, 14 (5): 758-765. 10.1038/aja.2012.25.CrossRefPubMedPubMedCentral
26.
go back to reference Terrault NA, Dodge JL, Murphy EL, Tavis JE, Kiss A, Levin TR, Gish RG, Busch MP, Reingold AL, Alter MJ: Sexual transmission of hepatitis C virus among monogamous heterosexual couples: the HCV partners study. Hepatology. 2013, 57 (3): 881-889. 10.1002/hep.26164.CrossRefPubMedPubMedCentral Terrault NA, Dodge JL, Murphy EL, Tavis JE, Kiss A, Levin TR, Gish RG, Busch MP, Reingold AL, Alter MJ: Sexual transmission of hepatitis C virus among monogamous heterosexual couples: the HCV partners study. Hepatology. 2013, 57 (3): 881-889. 10.1002/hep.26164.CrossRefPubMedPubMedCentral
27.
go back to reference Terrault NA: Sexual activity as a risk factor for hepatitis C. Hepatology. 2002, 36 (5 Suppl 1): S99-S105.CrossRefPubMed Terrault NA: Sexual activity as a risk factor for hepatitis C. Hepatology. 2002, 36 (5 Suppl 1): S99-S105.CrossRefPubMed
28.
go back to reference Vickerman P, Martin NK, Roy A, Beattie T, Jarlais DD, Strathdee S, Wiessing L, Hickman M, EMCDDA Collaborative Group: Is the HCV–HIV co-infection prevalence amongst injecting drug users a marker for the level of sexual and injection related HIV transmission?. Drug Alcohol Depend. 2013, 132: 172-181. 10.1016/j.drugalcdep.2013.01.020.CrossRefPubMed Vickerman P, Martin NK, Roy A, Beattie T, Jarlais DD, Strathdee S, Wiessing L, Hickman M, EMCDDA Collaborative Group: Is the HCV–HIV co-infection prevalence amongst injecting drug users a marker for the level of sexual and injection related HIV transmission?. Drug Alcohol Depend. 2013, 132: 172-181. 10.1016/j.drugalcdep.2013.01.020.CrossRefPubMed
29.
go back to reference Mo SD, Wang Z, Deng F, Zhang JH, Gong YH: Analysis of epidemiological characteristics and countermeasure of AIDS in Liangshan State. Mod Pre Med. 2008, 35: 630-631,635. (in Chinese) Mo SD, Wang Z, Deng F, Zhang JH, Gong YH: Analysis of epidemiological characteristics and countermeasure of AIDS in Liangshan State. Mod Pre Med. 2008, 35: 630-631,635. (in Chinese)
30.
go back to reference Weber R, Sabin CA, Friis-Møller N, Reiss P, El-Sadr WM, Kirk O, Dabis F, Law MG, Pradier C, De Wit S, Akerlund B, Calvo G, Monforte A, Rickenbach M, Ledergerber B, Phillips AN, Lundgren JD: Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch Intern Med. 2006, 166 (15): 1632-1641.CrossRefPubMed Weber R, Sabin CA, Friis-Møller N, Reiss P, El-Sadr WM, Kirk O, Dabis F, Law MG, Pradier C, De Wit S, Akerlund B, Calvo G, Monforte A, Rickenbach M, Ledergerber B, Phillips AN, Lundgren JD: Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch Intern Med. 2006, 166 (15): 1632-1641.CrossRefPubMed
31.
go back to reference Lewden C, Salmon D, Morlat P, Bévilacqua S, Jougla E, Bonnet F, Héripret L, Costagliola D, May T, Chêne G: Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS. Int J Epidemiol. 2005, 34 (1): 121-130.CrossRefPubMed Lewden C, Salmon D, Morlat P, Bévilacqua S, Jougla E, Bonnet F, Héripret L, Costagliola D, May T, Chêne G: Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS. Int J Epidemiol. 2005, 34 (1): 121-130.CrossRefPubMed
Metadata
Title
The geographic distribution patterns of HIV-, HCV- and co-infections among drug users in a national methadone maintenance treatment program in Southwest China
Authors
Yi-Biao Zhou
Song Liang
Qi-Xing Wang
Yu-Han Gong
Shi-Jiao Nie
Lei Nan
Ai-Hui Yang
Qiang Liao
Xiu-Xia Song
Qing-Wu Jiang
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2014
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-14-134

Other articles of this Issue 1/2014

BMC Infectious Diseases 1/2014 Go to the issue